Publications

Found 344 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2021
Windisch KA, Mazid S, Johnson MA, Ashirova E, Zhou Y, Gergoire L, Warwick S, McEwen BS, Kreek MJeanne, Milner TA.  2021.  Acute Delta 9-tetrahydrocannabinol administration differentially alters the hippocampal opioid system in adult female and male rats.. Synapse.
Magid-Bernstein JR, Li Y, Cho S-M, Piran PJ, Roh DJ, Gupta A, Shoamanesh A, Merkler A, Zhang C, Avadhani R et al..  2021.  Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials.. Neurology.
Magid-Bernstein JR, Li Y, Cho S-M, Piran PJ, Roh DJ, Gupta A, Shoamanesh A, Merkler A, Zhang C, Avadhani R et al..  2021.  Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials.. Neurology.
Palmer EE, Whitton C, Hashem MO, Clark RD, Ramanathan S, Starr LJ, Velasco D, De Dios JKarl, Singh E, Cormier-Daire V et al..  2021.  CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum.. Clin Genet.
Forgacs PB, Allen BB, Wu X, Gerber LM, Boddu S, Fakhar M, Stieg PE, Schiff ND, Mangat HS.  2021.  Corticothalamic Connectivity in Aneurysmal Subarachnoid Hemorrhage: Relationship with Disordered Consciousness and Clinical Outcomes.. Neurocrit Care.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Wolujewicz P, Aguiar-Pulido V, AbdelAleem A, Nair V, Thareja G, Suhre K, Shaw GM, Finnell RH, Elemento O, M Ross E.  2021.  Genome-wide investigation identifies a rare copy-number variant burden associated with human spina bifida.. Genet Med.
Wolujewicz P, Aguiar-Pulido V, AbdelAleem A, Nair V, Thareja G, Suhre K, Shaw GM, Finnell RH, Elemento O, M Ross E.  2021.  Genome-wide investigation identifies a rare copy-number variant burden associated with human spina bifida.. Genet Med.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.